Gulf International Bank UK Ltd Has $6.11 Million Holdings in CVS Health Co. (NYSE:CVS)

Gulf International Bank UK Ltd lessened its holdings in shares of CVS Health Co. (NYSE:CVS) by 4.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 97,142 shares of the pharmacy operator’s stock after selling 4,741 shares during the quarter. Gulf International Bank UK Ltd’s holdings in CVS Health were worth $6,108,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in the business. Livelsberger Financial Advisory bought a new position in CVS Health during the 3rd quarter worth about $31,000. Reston Wealth Management LLC bought a new position in CVS Health during the 3rd quarter worth about $32,000. First Community Trust NA increased its holdings in CVS Health by 116.2% during the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after purchasing an additional 302 shares in the last quarter. Kathleen S. Wright Associates Inc. bought a new position in CVS Health during the 3rd quarter worth about $33,000. Finally, ORG Partners LLC increased its holdings in CVS Health by 11,840.0% during the 2nd quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock worth $35,000 after purchasing an additional 592 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

CVS has been the subject of a number of research reports. Deutsche Bank Aktiengesellschaft lowered their target price on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a report on Friday, August 9th. TD Cowen upgraded CVS Health from a “hold” rating to a “buy” rating and upped their target price for the stock from $59.00 to $85.00 in a report on Friday, October 4th. Mizuho decreased their price target on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. Wells Fargo & Company dropped their price objective on CVS Health from $61.00 to $60.00 and set an “equal weight” rating on the stock in a research note on Monday. Finally, Evercore ISI increased their price objective on CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a report on Tuesday, October 8th. Nine investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $73.11.

CVS Health Stock Performance

CVS Health stock opened at $55.33 on Wednesday. CVS Health Co. has a 12-month low of $52.77 and a 12-month high of $83.25. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83. The business’s 50-day moving average price is $59.51 and its two-hundred day moving average price is $59.29. The stock has a market cap of $69.60 billion, a PE ratio of 9.85, a P/E/G ratio of 0.82 and a beta of 0.55.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.73 by $0.10. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The firm had revenue of $91.23 billion for the quarter, compared to analysts’ expectations of $91.41 billion. During the same quarter in the previous year, the business posted $2.21 earnings per share. The business’s revenue for the quarter was up 2.6% on a year-over-year basis. As a group, analysts expect that CVS Health Co. will post 6.41 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 annualized dividend and a yield of 4.81%. CVS Health’s dividend payout ratio is presently 47.33%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.